Smither John W

Director at GENELUX Corp · on record since Sep 14, 2023
Director at NewAmsterdam Pharma Co N.V. · on record since Dec 29, 2023
Chief Financial Officer at MBX Biosciences, Inc. · on record since Mar 18, 2026
Director at eFFECTOR Therapeutics, Inc. · on record since Aug 27, 2021
Chief Financial Officer at KYTHERA BIOPHARMACEUTICALS INC · on record since Oct 10, 2012
Director at Achaogen, Inc. · on record since Mar 13, 2014
Director at Attovia Therapeutics, Inc. · on record since Aug 4, 2026
Chief Financial Officer at Sienna Biopharmaceuticals, Inc. · on record since Apr 18, 2018
Director at Principia Biopharma Inc. · on record since Feb 21, 2019
Chief Financial Officer at Arcutis Biotherapeutics, Inc. · on record since Jan 30, 2020
Director at Arcutis Biotherapeutics, Inc. · on record since Mar 3, 2020
Director at Applied Molecular Transport Inc. · on record since Jan 31, 2022

Insider trading activity of Smither John W

Transactions on record: 204; since Feb 12, 2013

Open-market buys: 1

Open-market sells: 54; $8.7M

Companies traded: 10; last filing Sep 9, 2026

Figures computed from official regulatory filings — .

Companies where Smither John W has traded

NewAmsterdam Pharma Co N.V.6 tx · $40.5K · Sep 9, 2026
MBX Biosciences, Inc.2 tx · Aug 4, 2026
GENELUX Corp13 tx · $53.6K · Jul 2, 2026
Arcutis Biotherapeutics, Inc.38 tx · $673.7K · Feb 15, 2024
6 tx · Dec 28, 2023
7 tx · Jun 22, 2023
1 tx · Feb 21, 2019
6 tx · Jan 3, 2019
5 tx · Jun 7, 2018
120 tx · $9.8M · Oct 2, 2015

Track record of Smither John W

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Smither John W

Co-insiders of Smither John W

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NewAmsterdam Pharma Co N.V.Listing on record	Sep 9, 2026	Sell	-1,600	25.32 USD	$40.5K		SEC
MBX Biosciences, Inc.Listing unverified	Aug 4, 2026	AwardD (derivative)	130,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MBX Biosciences, Inc.Listing unverified	Aug 4, 2026	Award	28,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Jul 2, 2026	Sell	-12,000	2.91 USD	$34.9K		SEC
GENELUX CorpListing on record	Jun 18, 2026	Award	28,409	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Jun 18, 2026	AwardD (derivative)	31,566	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 9, 2026	Award	3,400	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 9, 2026	AwardD (derivative)	15,300	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Aug 29, 2025	AwardD (derivative)	28,576	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Aug 29, 2025	Award	22,283	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 8, 2025	Award	6,960	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 8, 2025	AwardD (derivative)	32,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Dec 31, 2024	AwardD (derivative)	50,469	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Aug 5, 2024	AwardD (derivative)	50,469	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Aug 5, 2024	Award	39,541	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Jun 7, 2024	BuyD (derivative)	6,250	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
GENELUX CorpListing on record	Jun 7, 2024	Buy	6,250	—	n/a (No price was disclosed in the filing)	conv 86ClusterFirst in 12mo	SEC
Arcutis Biotherapeutics, Inc.Listing on record	Feb 15, 2024	OtherD (derivative)	-25,718	—	n/a (No price was disclosed in the filing)		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Feb 15, 2024	OtherD (derivative)	-8,379	—	n/a (No price was disclosed in the filing)		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Feb 15, 2024	Award	2,793	—	n/a (No price was disclosed in the filing)		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Feb 15, 2024	Award	8,572	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 3, 2024	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Applied Molecular Transport Inc.Listing unverified	Dec 28, 2023	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Applied Molecular Transport Inc.Listing unverified	Dec 28, 2023	OtherD (derivative)	-60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Applied Molecular Transport Inc.Listing unverified	Dec 28, 2023	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NewAmsterdam Pharma Co N.V.Listing on record	Sep 9, 2026	Sell	-1,600	25.32 USD	$40.5K		SEC
MBX Biosciences, Inc.Listing unverified	Aug 4, 2026	AwardD (derivative)	130,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MBX Biosciences, Inc.Listing unverified	Aug 4, 2026	Award	28,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Jul 2, 2026	Sell	-12,000	2.91 USD	$34.9K		SEC
GENELUX CorpListing on record	Jun 18, 2026	Award	28,409	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Jun 18, 2026	AwardD (derivative)	31,566	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 9, 2026	Award	3,400	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 9, 2026	AwardD (derivative)	15,300	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Aug 29, 2025	AwardD (derivative)	28,576	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Aug 29, 2025	Award	22,283	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 8, 2025	Award	6,960	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 8, 2025	AwardD (derivative)	32,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Dec 31, 2024	AwardD (derivative)	50,469	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Aug 5, 2024	AwardD (derivative)	50,469	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Aug 5, 2024	Award	39,541	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENELUX CorpListing on record	Jun 7, 2024	BuyD (derivative)	6,250	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
GENELUX CorpListing on record	Jun 7, 2024	Buy	6,250	—	n/a (No price was disclosed in the filing)	conv 86ClusterFirst in 12mo	SEC
Arcutis Biotherapeutics, Inc.Listing on record	Feb 15, 2024	OtherD (derivative)	-25,718	—	n/a (No price was disclosed in the filing)		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Feb 15, 2024	OtherD (derivative)	-8,379	—	n/a (No price was disclosed in the filing)		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Feb 15, 2024	Award	2,793	—	n/a (No price was disclosed in the filing)		SEC
Arcutis Biotherapeutics, Inc.Listing on record	Feb 15, 2024	Award	8,572	—	n/a (No price was disclosed in the filing)		SEC
NewAmsterdam Pharma Co N.V.Listing on record	Jan 3, 2024	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Applied Molecular Transport Inc.Listing unverified	Dec 28, 2023	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Applied Molecular Transport Inc.Listing unverified	Dec 28, 2023	OtherD (derivative)	-60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Applied Molecular Transport Inc.Listing unverified	Dec 28, 2023	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC